HAEMONETICS CORPORATION (NYSE:HAE) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
HAEMONETICS CORPORATION (NYSE:HAE) Files An 8-K Results of Operations and Financial Condition
EX-99.1 2 ex991-q4mar2019earningsrel.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Earnings Release FY19 Q4Investor ContactsMedia Contact Gerry Gould,…
To view the full exhibit click
here
About HAEMONETICS CORPORATION (NYSE:HAE)
Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company’s segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection.